Related Experiment Video

Updated: Sep 20, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.4K

How to Conduct Clinical Trials of Personalized Cancer Therapies

Sean Clark-Garvey1, Matthew I Milowsky1

  • 1Department of Medicine, Division of Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.

European Urology Focus
|June 6, 2022
PubMed

Insights

Three key principles guide personalized cancer therapy clinical trials: integrating molecular cancer biology, using biomarkers for targeted treatments, and employing innovative trial designs for better outcomes.

Area of Science:

  • Oncology
  • Clinical Trial Design
  • Translational Medicine

Background:

  • Personalized cancer therapies require optimized clinical trial strategies.
  • Advances in molecular cancer biology necessitate updated trial designs.
  • Biomarker identification is crucial for effective targeted cancer treatments.

Purpose of the Study:

  • To outline essential principles for designing effective clinical trials of personalized cancer therapies.
  • To emphasize the integration of molecular biology and biomarker strategies in trial development.
  • To highlight the importance of innovative approaches in cancer clinical trial design.

Main Methods:

  • Literature review and synthesis of current best practices in oncology clinical trials.
  • Analysis of the role of molecular cancer biology in therapeutic development.
  • Evaluation of biomarker utility and innovative trial designs for personalized medicine.

Main Results:

  • Identification of three core principles for guiding personalized cancer therapy trials.
  • Principle 1: Incorporating advances in molecular cancer biology into trial design.
  • Principle 2: Including biomarkers to guide rational therapy selection and Principle 3: Utilizing innovative trial designs.

Conclusions:

  • Adherence to these principles can enhance the efficiency and success of personalized cancer therapy clinical trials.
  • Integrating molecular insights, biomarkers, and novel designs is paramount for advancing precision oncology.
  • These guidelines aim to optimize the development and delivery of targeted cancer treatments.

More Related Videos

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids08:52

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on: November 22, 2021

4.2K
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

5.1K

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
9.3K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
523
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
677
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K